Published in Surgery on December 01, 1995
Adrenal cortical carcinoma. World J Surg (2001) 1.74
Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center. Eur J Endocrinol (2013) 1.16
Insulin growth factor receptor (IGF-1R) antibody cixutumumab combined with the mTOR inhibitor temsirolimus in patients with metastatic adrenocortical carcinoma. Br J Cancer (2013) 1.06
Adrenocortical Carcinoma: Current Therapeutic State-of-the-Art. J Oncol (2012) 1.05
Liver resection and ablation for metastatic adrenocortical carcinoma. Ann Surg Oncol (2011) 0.92
Current and emerging therapies for advanced adrenocortical carcinoma. Oncologist (2011) 0.92
Alpha-fetoprotein (AFP)-producing adrenocortical carcinoma--long survival with various therapeutic strategies including a lung resection: report of a case. Surg Today (2008) 0.91
A retrospective cohort analysis of the efficacy of adjuvant radiotherapy after primary surgical resection in patients with adrenocortical carcinoma. J Clin Endocrinol Metab (2012) 0.91
A rare case of an aldosterone secreting metastatic adrenocortical carcinoma and papillary thyroid carcinoma in a 31-year-old male. Rare Tumors (2011) 0.84
Proposal for modification of the ENSAT staging system for adrenocortical carcinoma using tumor grade. Langenbecks Arch Surg (2010) 0.84
Combined liver and inferior vena cava resection for adrenocortical carcinoma. Surg Today (2007) 0.84
[Current TNM classification systems for adrenocortical carcinoma]. Pathologe (2010) 0.84
Giant adrenal pseudocyst harbouring adrenocortical cancer. BMJ Case Rep (2011) 0.77
Classic Cushing's syndrome in a patient with adrenocortical carcinoma. Radiol Case Rep (2015) 0.75
Successful treatment of adrenocortical carcinoma with pulmonary metastasis in a child: report of a case. Surg Today (2008) 0.75
Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet (1979) 12.29
Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab (2001) 6.12
Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet (1979) 6.10
Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science (1995) 4.25
Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial. J Clin Oncol (2001) 4.09
Development of WHO guidelines on generalized cost-effectiveness analysis. Health Econ (2000) 3.95
Is dialysis hypotension caused by an abnormality of venous tone? Br Med J (Clin Res Ed) (1988) 3.48
The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. Clin Cancer Res (1999) 3.36
Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol (1997) 2.75
Cyclosporin A in cadaveric organ transplantation. Br Med J (Clin Res Ed) (1981) 2.67
Regulation of alternative polyadenylation by U1 snRNPs and SRp20. Mol Cell Biol (1998) 2.26
Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration. Ann Surg Oncol (2001) 2.24
Cyclosporine: five years' experience in cadaveric renal transplantation. N Engl J Med (1984) 2.10
An intron enhancer recognized by splicing factors activates polyadenylation. Genes Dev (1996) 2.08
Polypyrimidine tract-binding protein positively regulates inclusion of an alternative 3'-terminal exon. Mol Cell Biol (1999) 2.05
Increased efficiency of calcium absorption during short periods of inadequate calcium intake in girls. Am J Clin Nutr (1996) 2.04
Anaplastic carcinoma of the thyroid. A clinicopathologic study of 121 cases. Cancer (1990) 2.01
Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease. Ann Surg (1997) 2.00
Cyclosporin A: preliminary observations in dogs with pancreatic duodenal allografts and patients with cadaveric renal transplants. Transplant Proc (1979) 1.94
Changes in leucocyte migration after renal transplantation. Br Med J (1969) 1.91
Blood loss using the modified two-layer Kiil dialyser. Br Med J (1967) 1.89
Stochastic league tables: communicating cost-effectiveness results to decision-makers. Health Econ (2001) 1.89
Improving adherence to malaria treatment for children: the use of pre-packed chloroquine tablets vs. chloroquine syrup. Trop Med Int Health (2001) 1.88
Effect of preoperative biliary decompression on pancreaticoduodenectomy-associated morbidity in 300 consecutive patients. Ann Surg (2001) 1.87
The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients. J Clin Endocrinol Metab (1992) 1.86
Intra-abdominal desmoplastic small cell tumor: a light microscopic, immunocytochemical, ultrastructural, and flow cytometric study. Hum Pathol (1993) 1.80
Calcitriol: the major humoral mediator of hypercalcemia in Hodgkin's disease and non-Hodgkin's lymphomas. Blood (1993) 1.80
Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer [seecomments]. Ann Surg Oncol (1998) 1.78
Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group. Ann Surg (1996) 1.77
Vascular involvement in pancreatic adenocarcinoma: reassessment by thin-section CT. Abdom Imaging (1996) 1.76
Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma. J Clin Oncol (1998) 1.76
Calcitriol production in hypercalcemic and normocalcemic patients with non-Hodgkin lymphoma. Ann Intern Med (1994) 1.75
Adrenal cortical carcinoma. World J Surg (2001) 1.74
What are the priorities for prevention and control of non-communicable diseases and injuries in sub-Saharan Africa and South East Asia? BMJ (2012) 1.72
Gastrointestinal complications after renal transplantation. Lancet (1971) 1.71
Pancreatic leak after left pancreatectomy is reduced following main pancreatic duct ligation. Br J Surg (2003) 1.71
The need for standardized pathologic staging of pancreaticoduodenectomy specimens. Pancreas (1996) 1.68
Liver transplantation in man. II. A report of two orthotopic liver transplants in adult recipients. Br Med J (1968) 1.68
An intron enhancer containing a 5' splice site sequence in the human calcitonin/calcitonin gene-related peptide gene. Mol Cell Biol (1995) 1.67
"Inflammatory pseudotumor": what is it? How does it behave? Ann Otol Rhinol Laryngol (1995) 1.65
Cost and utilization impact of a clinical pathway for patients undergoing pancreaticoduodenectomy. Ann Surg Oncol (2000) 1.65
Proliferative verrucous leukoplakia and its related lesions. Oral Oncol (1999) 1.63
Nonfunctioning islet cell carcinoma of the pancreas: survival results in a contemporary series of 163 patients. Surgery (2001) 1.60
Fine-needle aspiration of salivary glands: its utility and tissue effects. Ann Otol Rhinol Laryngol (1992) 1.59
Laparoscopy in the staging of pancreatic cancer. Br J Surg (2001) 1.59
Pharmacologic intervention can reestablish baseline hemodynamic parameters during laparoscopy. Surgery (1994) 1.59
A multispecialty approach to the diagnosis and management of pancreatic cancer. Am J Gastroenterol (2000) 1.58
Ki-67 immunostaining in node-negative stage I/II breast carcinoma. Significant correlation with prognosis. Cancer (1991) 1.57
Pharmacology of nadolol (SQ 11725), a beta-adrenergic antagonist lacking direct myocardial depression. Eur J Pharmacol (1976) 1.57
Evidence that c-myc mediated apoptosis does not require wild-type p53 during lymphomagenesis. Oncogene (1995) 1.55
Impact of prepackaging antimalarial drugs on cost to patients and compliance with treatment. Bull World Health Organ (2001) 1.55
Association of gastric adenocarcinoma with the HLA class II gene DQB10301. Gastroenterology (1996) 1.54
Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients. Medicine (Baltimore) (1984) 1.51
The role of glucagon administration in the diagnosis and treatment of patients with tumor hypoglycemia. Cancer (1998) 1.50
Chemoimmunotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and bacillus calmette--guérin. N Engl J Med (1974) 1.48
Phase II clinical investigation of gemcitabine in advanced soft tissue sarcomas and window evaluation of dose rate on gemcitabine triphosphate accumulation. J Clin Oncol (2001) 1.47
Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms. Clin Cancer Res (2000) 1.47
Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma. Clin Cancer Res (2001) 1.46
Results of two consecutive trials of dose-intensive chemotherapy with doxorubicin and ifosfamide in patients with sarcomas. Am J Clin Oncol (1998) 1.45
Role of DTIC (NSC-45388) in the chemotherapy of sarcomas. Cancer Treat Rep (1976) 1.45
Metastatic patterns of choroidal melanoma. Cancer (1974) 1.45
Long-term outcome of patients with American Joint Committee on Cancer stage IIB extremity soft tissue sarcomas. J Clin Oncol (1999) 1.45
Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma. Am J Surg (1997) 1.44
Corticosteroid-induced inhibition of adrenal androgen production in selected patients with prostate cancer. Endocr Pract (2001) 1.44
Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications. Am J Pathol (1995) 1.44
The osteoclast-associated protease cathepsin K is expressed in human breast carcinoma. Cancer Res (1997) 1.43
Exophytic signet-ring cell carcinoma of the colorectum. Arch Pathol Lab Med (1991) 1.43
Papillary neoplasms (Heffner's tumors) of the endolymphatic sac. Ann Otol Rhinol Laryngol (1993) 1.42
Plasma lipids following renal transplantation. Transplantation (1973) 1.42
Adenosine receptors mediating cardiac depression. Life Sci (1982) 1.41
The safety and cost-effectiveness of low osmolar contrast media. Can economic analysis determine the real worth of a new technology? Med J Aust (1991) 1.40
Pelvic exenteration for locally advanced rectal carcinoma: factors predicting improved survival. Surgery (1997) 1.40
Hib disease must be prevented. Med J Aust (1994) 1.39
Intraluminal crystalloids in struma ovarii. Immunohistochemical, DNA flow cytometric, and ultrastructural study. Arch Pathol Lab Med (1991) 1.39
Hepatitis A epidemiology in Australia: national seroprevalence and notifications. Med J Aust (2001) 1.38
Hormone replacement therapy and breast cancer. Ann Surg Oncol (1999) 1.38
Multiple molecular forms of cyclic nucleotide phosphodiesterase in cardiac and smooth muscle and in platelets. Isolation, characterization, and effects of various reference phosphodiesterase inhibitors and cardiotonic agents. Biochem Pharmacol (1986) 1.37
Adrenal cortical carcinoma. Cancer (1989) 1.37
Ewing's sarcoma and peripheral primitive neuroectodermal tumor: an interim report. Ann Otol Rhinol Laryngol (1996) 1.36
Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head. Br J Surg (1998) 1.35
Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head. Am J Surg (1996) 1.35
High-dose ifosfamide in bone and soft tissue sarcomas: results of phase II and pilot studies--dose-response and schedule dependence. J Clin Oncol (1997) 1.34
Induction of p21waf1 expression and growth inhibition by transforming growth factor beta involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells. Cancer Res (1997) 1.34
Postoperative radiotherapy for malignant tumors of the parotid gland. Int J Radiat Oncol Biol Phys (1997) 1.33
Epithelial-myoepithelial carcinoma of salivary glands. Ann Otol Rhinol Laryngol (1992) 1.33
Beta-lactam antibiotics alone or in combination with gentamicin for therapy of gram-negative bacillary infections in neutropenic patients. Am J Med Sci (1976) 1.32
Diffuse and localized tenosynovial giant cell tumor and pigmented villonodular synovitis: a clinicopathologic and flow cytometric DNA analysis. Hum Pathol (1992) 1.32
Identification of exon sequences and an exon binding protein involved in alternative RNA splicing of calcitonin/CGRP. Nucleic Acids Res (1992) 1.31
Salivary gland tumors in children. Ann Otol Rhinol Laryngol (1991) 1.30
Cell cycle-dependent cytotoxicity, G2/M phase arrest, and disruption of p34cdc2/cyclin B1 activity induced by doxorubicin in synchronized P388 cells. Mol Pharmacol (1996) 1.29
Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma. J Clin Oncol (1998) 1.29
Clotrimazole (Bay b 5097): in vitro and clinical pharmacological studies. Antimicrob Agents Chemother (1972) 1.28
Arthritic calcitonin/alpha calcitonin gene-related peptide knockout mice have reduced nociceptive hypersensitivity. Pain (2001) 1.27
Chemoimmunotherapy of adult acute leukaemia. Prolongation of remission in myeloblastic leukaemia with B.C.G. Lancet (1974) 1.27
Kidney graft survival and matching for HL-A and ABO antigens. Nature (1973) 1.27